Protocatechuic Acid
CAS 99-50-3
Protocatechuic Acid (CAS 99-50-3) is a pharmaceutical compound with 10 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 523268.1619047619 nM | 21 | - |
| - | Ki | 11517.857142857143 nM | 14 | - |
| - | Potency | 31034.024999999998 nM | 12 | - |
| - | IC50 | 14.014000000000001 ug.mL-1 | 5 | - |
| - | MIC | 50 ug | 5 | - |
| - | EC50 | 27861.85 nM | 4 | - |
| - | EC50 | 3.05 ug.mL-1 | 2 | - |
| - | Kd | 146500 nM | 2 | - |
| - | MIC | 649350 nM | 1 | - |
| - | MIC | 3200 ug.mL-1 | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Protocatechuic Acid used for in pharmaceutical contexts?
Protocatechuic Acid (CAS 99-50-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Protocatechuic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Protocatechuic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Protocatechuic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Protocatechuic Acid with EU status "permitted".
What clinical phase is Protocatechuic Acid in?
No phase 1-4 clinical development badge is rendered for Protocatechuic Acid because the matched compound identifier rows do not contain a max-phase value.